+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 70Years
All Genders
ID06793332

Phase II Study of Ivonescimab Combined With TROP2 ADC for Treating Brain Metastases in Adults With Triple-Negative Breast Cancer

Led by Fudan University · Updated on 2025-01-27

39

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying treatment options for patients with triple-negative breast cancer TNBC that has spread to the brain. This condition is serious, with a poor prognosis and median survival of less than six months. The study aims to explore the effectiveness and safety of combining ivonescimab with TROP2 antibody-drug conjugates such as sacituzumab govitecan in treating these brain metastases. This is a phase II, single-arm, prospective clinical trial focusing on this patient group. Participants will receive ivonescimab at 20 mgkg intravenously on day 1 every three weeks, combined with sacituzumab govitecan at 10 mgkg intravenously on days 1 and 8 every three weeks. Treatment continues until the disease progresses, intolerable side effects occur, consent is withdrawn, or the investigator decides to stop medication. The study includes patients with untreated brain metastases and those with progression after radiotherapy. Various biological samples will be collected for exploratory molecular analysis. During the study, participants will undergo brain MRI to confirm metastases and regular assessments to monitor tumor response, including the primary outcome of intracranial objective response rate within about 12 weeks. Secondary outcomes include clinical benefit rate, progression-free survival, and overall survival, with follow-up extending up to approximately 30 months. Safety, laboratory tests, and patients overall health will be closely monitored throughout the trial period.

CONDITIONS

Brief Title

BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC

Research Team

J

Jian Zhang, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here